CS Paper Radar

ClinGuard: a governance framework for reliable, transparent, and auditable clinical coordination

Kaiyuan Wu, Aditya Nagori, Nicoleta J. Economou, Robert M. Califf, Rishikesan Kamaleswaran

cs.CY ·submitted 2026-10-22 14:36 UTC · v1
published

Abstract

ClinGuard is a model-agnostic governance framework that treats clinical coordination as patient-scoped, policy-bound transactions rather than free text. An independent sentinel layer validates and governs agent-proposed actions, escalates when needed, and executes approved actions through limited-privilege connectors. Each transaction is linked to a tamper-evident audit record, while an outcomes monitor informs future autonomy decisions. Using MIMIC-IV-FHIR and skilled-nursing-facility placement, we distinguish retrospective demonstration from proposed prospective evaluation in this work.

Comment
Perspective, accepted at npj Health Systems

Closest papers

Nearest neighbours by meaning across the whole index.

ETHOS: Towards a Modular Ethics Framework for Clinical Multi-Agent Systems

cs.MA cs.AIcs.LG ·2026-08-15 ·Rakesh Sharma, Sydney Pugh, Cameron Beeche, Pankhuri Singhal, Rachel Wu +12 more
similarity 0.64
Abstract · Preprint of an article submitted for consideration in Pacific Symposium on Biocomputing ©2027 World Scientific Publishing Company. \url{http…

The rapid adoption of large language models has enabled the development of clinical multi-agent systems (MAS) capable of integrating multimodal patient data and supporting increasingly complex clinical decision-making. However, the deployment of these systems in real-world healthcare settings raises critical ethical concerns related to safety, fairness, accountability, transparency, and patient trust. While numerous organizations, including the World Health Organization, the National Academy of Medicine, and the FUTURE-AI consortium, have proposed ethical frameworks and governance principles for healthcare AI, these efforts remain largely conceptual. To address this challenge, we present ETHOS (Ethics and Trust through Hierarchical Oversight System), a modular ethics framework designed as a governance meta-agent that can be integrated with any existing multi-agent system without requiring changes to its underlying architecture. ETHOS translates stakeholder-informed ethical requirements into executable runtime oversight through a layered governance approach consisting of deterministic checks, contextual reviews, and a final ethics critic. These components continuously evaluate intermediate reasoning steps and final outputs, enabling the system to identify ethical risks, request revisions, or suppress responses that fail predefined safety and trustworthiness criteria. We demonstrate ETHOS within a hepatology clinical decision-support MAS. Results show that ETHOS improves decision reliability by detecting incomplete, inconsistent, or out-of-scope evidence and appropriately increasing abstention when safe recommendations cannot be supported. By embedding ethical governance directly into system operation, ETHOS provides a practical and auditable mechanism for transforming high-level AI ethics principles into deployable safeguards.

0.17

From AI-Enabled Remote Patient Monitoring Toward Agentic Robotics: Embodiment, Governance, and Care Integration

cs.RO cs.AIcs.MAcs.SE+1 ·2026-11-13 ·Ivana Ragusa, Lorenzo Guiducci, Filippo Cavallo
published similarity 0.60
Abstract · 34 pages, 6 figures, 3 tables. Accepted for publication in Annual Review of Control, Robotics, and Autonomous Systems, Volume 10 (2027)

AI-enabled remote patient monitoring is evolving beyond passive data collection toward agentic AI systems that interpret patient states, coordinate care, and initiate action across domestic and clinical settings. This structured scoping review finds that mature agentic care has not yet emerged: Most systems remain human led, while stronger decision-action coupling and embodied AI remain largely confined to prototypes and pilots. Healthcare robotics makes the transition from monitoring to action especially visible by translating AI-generated recommendations and decisions into speech, movement, prompting, physical assistance, escalation, and care coordination, making embodiment, clinical integration, human oversight, and governance fundamental design requirements. Further progress requires safe and interoperable care architectures in which intelligent components operate through clinically validated and accountable workflows. We propose agentic robotics as a future direction for supervised systems embedded in the care ecosystem, connecting AI agents and robots with clinicians, caregivers, and patients through auditable workflows that can be interrupted and remain subject to human oversight and explicit AI governance.

0.47

Governed AI-Agent Coordination for Dementia Care: Architecture, Safety Contracts, and Evidence-Derived Workflow Verification

cs.MA ·2026-09-22 ·Francesca Medda, Hui Gong
similarity 0.58
Abstract · 16 pages, 2 figures, 6 tables. Includes an executable architecture-verification harness with 18 requirement-derived traces and six component…

Dementia care at home increasingly involves connected sensors, medication devices, electronic records, and assistive technologies. Professionals and family carers must still interpret these observations, reconstruct context, coordinate responses, and verify resolution. Sustaining safe care at home while ensuring timely clinical escalation requires continuity between these tasks. Agentic engineering creates a systems opportunity by combining model interpretation with persistent external memory, planning, authorised tool use, and outcome feedback. This paper presents Governed Closed-loop Agent Coordination (GCAC), an architecture for bounded agent participation in community dementia-care workflows. Evidence on coordination failures and policy obligations is translated into traceable system requirements. GCAC separates observation, four governed memory classes, planning, deterministic policy enforcement, execution, and outcome monitoring through a typed event-memory-decision-action-outcome contract. A worked medication-device example explains how these roles maintain context, allocate responsibility, and distinguish an unrecorded dose from a clinically established omission. A reference harness evaluates 18 evidence-derived traces spanning care gaps, service failure, consent change, stale state, duplicate events, untrusted text, and acute-change routing. GCAC satisfies all 18 contract oracles with zero policy-violating tool calls; event-threshold and stateless-planner controls satisfy 2/18 and 1/18, respectively. Six ablations identify the contribution of memory, policy, and versioning. The results establish architectural conformance. Effects on hospital use, quality of life, staff workload, unpaid care, and net costs require prospective evaluation. GCAC provides a testable basis for accountable coordination that preserves human authority over consequential care decisions.

0.24

MedHarnessBench: A Unified Benchmark for Healthcare Agent Evaluation

cs.AI ·2026-10-11 ·Rui Tang, Hongqiu Wang
benchmarkcode/data similarity 0.58
Abstract

Healthcare agents must transform longitudinal clinical evidence into reliable actions through heterogeneous tools and stateful workflows, conditions under which model-centric systems may lose context, misuse tools, fail to verify consequential transitions, or cross authorization boundaries. Existing medical-agent benchmarks primarily emphasize terminal task outcomes, making it difficult to determine whether execution failures arise from the agent model, the runtime harness, or their interaction. We present the Medical Harness Protocol, an outcome-preserving framework that independently evaluates seven healthcare-specific process dimensions: Care Action Fulfillment, Clinical Resource Competence, Patient-Evidence Alignment, Clinical Workflow Continuity, Clinical Auditability, Closed-Loop Verification, and Clinical Conduct Boundaries. A normalized intervention trace further tracks whether runtime support is available, activated, delivered, adopted by the agent, and propagated into subsequent behavior. We instantiate the protocol as MedHarnessBench, comprising 342 executable tasks across FHIR/EHR operations, healthcare-administration interfaces, and multimodal clinical tools. Across more than 16,000 controlled task executions, MedHarness yields broad improvements in terminal task success, intermediate subtask completion, and healthcare-specific process quality. We further evaluate MedHarness against multiple general-purpose harnesses and use controlled single-fault perturbations to verify the sensitivity and discrimination of the seven-dimensional evaluation. These results demonstrate that healthcare-specific runtime support can substantially improve both task completion and execution quality, while revealing failures that terminal outcomes alone cannot capture. Code and resources are available at https://github.com/Tomry1114/Awesome-Agent-Harness-for-Healthcare.

0.20

Trust Is Not a Score: Runtime Assurance Contracts for High-Risk AI Agents

cs.AI cs.CYcs.SE ·2026-09-30 ·Serhii Zabolotnii
code/data similarity 0.58
Abstract · 18 pages, 2 figures, 5 tables. v2 corrects the agentic-coding study (174 distinct mechanisms replace 280 index-cloned cases) and adds an ind…

Benchmarks, audits, and agent protocols describe performance, permissions, and repair, but not how observed evidence should change an agent's authority during a consequential task. We propose a Runtime Assurance Contract (RAC), a policy-level formal schema binding autonomy boundaries, component eligibility, evidence state, transition policy, human-review capacity, and non-compensatory gates. Under RAC, soft metrics may inform routing, whereas a failed or unknown mandatory gate forces retry, switch, escalation, deferral, or stop; aggregate performance cannot authorize action. We define the contract, an evidence record, a permission rule, and five invariants. A deterministic failure-injection study in agentic coding evaluates 174 cases, each a distinct mechanism, under a gate conjunction, a score-only rule, and a restricted protocol baseline. At the published example weights and threshold, the score rule admits 56 of 63 block-required injections and all 24 review-required injections; tuned in hindsight, it matches the conjunction case for case. For positive weights, a positive threshold, binary risk signals, and each signal firing alone on some case, the two rules agree on every case if and only if the threshold does not exceed the smallest weight. On 124 further cases written blind by a model of another vendor, the conjunction itself admits 35 of 79 injections, and so does the tuned score rule: a missing detector is invisible to every decision rule. Eighteen hand-authored traces check version-pinned evidence and review transitions. In a prospective synthetic holdout of 24 episodes, RAC and a separately implemented full stateful baseline both match the labels of two blinded LLM judges. These studies test mechanisms on synthetic cases; they establish neither deployed safety nor cross-domain effectiveness.

0.26

PRISMATIC : Prescription Risk Inspection System for Multi-Agent Treatment Interaction in Clinical Decision-Making

cs.CL cs.AI ·2026-10-14 ·Ziyang Ling, Shuyu Lu, Ziyi Chen
hot direction similarity 0.56
Abstract

Medical prescribing errors for multimorbid patients, who require complex drug regimens, are a major patient safety concern. These errors often stem from fragmented decision-making across medical specialties, a critical coordination failure that leads to adverse drug events and rehospitalizations. To address this coordination challenge, we introduce PRISMATIC, a multi-agent architecture where specialized agents, each representing a workflow role, collaboratively generate and refine treatment plans. Operating on a blackboard architecture, the system first structures patient information from clinical notes, then iteratively develops safe, rational, and interpretable drug regimens. The agents' collaboration is governed by two novel adaptive coordination mechanisms: (1) Dynamic Self-Updating Weight Adjustment (DSWA), a long-term mechanism that adjusts the influence weights of agents based on historical case outcomes, enabling the system to adapt and trust more reliable specialists over time. (2) Discrepancy Feedback Precise Calibration (DFPC), a short-term mechanism where agents provide iterative feedback to resolve disagreements and eliminate prescription conflicts for the current patient. Experiments on patient records from the MIMIC-IV database show that PRISMATIC significantly reduces drug conflicts, improves prescription coverage, and enhances treatment consistency compared to strong LLM baselines. Our work demonstrates that structuring clinical co-treatment as a multi-agent coordination problem offers a promising path toward safer and more coherent multidisease management.

0.29

MediSkill-Evo: Process-Constrained Self-Evolution for Evidence-Grounded Clinical Interaction

cs.AI ·2026-08-24 ·Ruoyu Wu, Shenfu Xie, Yinqian Sun, Haibo Tong, Feifei Zhao
code/data similarity 0.56
Abstract

Interactive clinical agents operate under partial observability, so reliable care depends on reaching the correct diagnosis through evidence-grounded, safe interactions. Yet existing agents struggle to convert experience into reusable process knowledge with explicit provenance and authority. To address this gap, we introduce MediSkill-Evo, which self-evolves governed process knowledge without fine-tuning the backbone. It realizes this self-evolution by updating clinical, process, symbolic, and visual knowledge in four typed banks under type-specific validation and scope rules. The Process-Constrained Preference Harness then turns validated knowledge into action by grounding candidates in evidence and prioritizing safer decisions. We evaluate on 300 MIMIC-IV-derived FullChain encounters, 180 hard-isolation conditions covering six process obligations, and 100 multimodal NEJM image-diagnosis cases. On Qwen FullChain, MediSkill-Evo improves diagnosis accuracy by 7.81% and treatment-intent coverage by 70.67% over the best-performing prior agent, while reducing critical failures by 43.04%. Under stress, it improves the stress-process composite by 7.77% and required-action completion by 12.41% over the best-performing agent for each metric, with stronger patient-fact, temporal-evidence, and triage-red-flag recovery and no controller-scored errors in unavailable-evidence, treatment, and triage safety checks. On multimodal NEJM diagnosis, MediSkill-Evo with optional MedSAM localization improves diagnosis accuracy by 2.56% and core score by 18.96% over the best-performing memory agent. Code is available at https://anonymous.4open.science/r/mediskill-evo_anonymous-68E7.

0.66

VITAL: A Framework for Validating Agentic AI in Pharmaceutical Drug Development and Clinical Trial Operations

cs.AI ·2026-11-17 ·Sandeep Burugupalli, Pedro Matos-Filipe, Andrea Hita Ardiaca, Adam Taylor, Alex Grigorenko +8 more
similarity 0.55
Abstract

Current assurance approaches do not establish whether evidence is sufficient to validate, monitor and govern agentic artificial intelligence (AI) within a pharmaceutical context of use. Plausible outputs may conceal failures in retrieval, reasoning, orchestration or human-control points, where reference standards are unavailable. We developed and operationalised VITAL (Validation by Intended use, Traceability, Autonomy and Lifecycle evidence), a validation framework for agents in clinical development, through landscape analysis, regulatory and standards mapping, expert interviews and multi-stakeholder refinement. VITAL integrates context of use, controls, behavioural validation and lifecycle evidence within a risk-adjusted framework. We applied VITAL across epidemiology and treatment-landscape analysis, site selection, enrolment rescue and trial-design trade-off support to translate autonomy, reversibility, transparency and patient impact into proportionate validation activities, evidence requirements and auditable reconstruction of system behaviour. VITAL may inform evidence requirements and lifecycle accountability for higher-risk pharmaceutical uses; evaluation should assess reproducibility across assessors, organisations and system configurations.

0.29